Laboratory medicine and medical oncology: the tale of two Cinderellas

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F13%3A33145169" target="_blank" >RIV/61989592:15110/13:33145169 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1515/cclm-2012-0496" target="_blank" >http://dx.doi.org/10.1515/cclm-2012-0496</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1515/cclm-2012-0496" target="_blank" >10.1515/cclm-2012-0496</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Laboratory medicine and medical oncology: the tale of two Cinderellas

Popis výsledku v původním jazyce

Cancer represents a leading cause of death in the developed countries. The past 50 years have witnessed major progress in both laboratory medicine and clinical oncology that has translated into improved prognosis of cancer patients. From the humble beginnings as unrelated specialties, major advances in the understanding of molecular bases of cancer progression led to increased interactions between laboratory medicine and clinical ( mostly medical) oncology. Laboratory medicine is now an integral part ofthe management of cancer patients. The many aspects of the role of laboratory medicine in clinical oncology include the determination of biomarkers that are used in establishing the diagnosis, predicting response to therapy or prognosis, study of the host response to tumor growth, detection of treatment toxicity and determining the concentrations of anticancer drugs.

Název v anglickém jazyce

Laboratory medicine and medical oncology: the tale of two Cinderellas

Popis výsledku anglicky

Cancer represents a leading cause of death in the developed countries. The past 50 years have witnessed major progress in both laboratory medicine and clinical oncology that has translated into improved prognosis of cancer patients. From the humble beginnings as unrelated specialties, major advances in the understanding of molecular bases of cancer progression led to increased interactions between laboratory medicine and clinical ( mostly medical) oncology. Laboratory medicine is now an integral part ofthe management of cancer patients. The many aspects of the role of laboratory medicine in clinical oncology include the determination of biomarkers that are used in establishing the diagnosis, predicting response to therapy or prognosis, study of the host response to tumor growth, detection of treatment toxicity and determining the concentrations of anticancer drugs.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Clinical Chemistry and Laboratory Medicine

ISSN

1434-6621

e-ISSN

—

Svazek periodika

51

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

DE - Spolková republika Německo

Počet stran výsledku

14

Strana od-do

99-112

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—